Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions
Introduction: Mirogabalin is a new drug from the gabapentinoid group first registered in Japan in 2019. It has found use in the treatment of peripheral neuropathic pain in diabetic neuropathy and postherpetic neuropathy. Purpose: In this article, we review studies on the efficacy and safety of mi...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nicolaus Copernicus University in Toruń
2023-01-01
|
| Series: | Quality in Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/QS/article/view/41950 |
| _version_ | 1811176035614457856 |
|---|---|
| author | Weronika Gawel Sylwia Zdun Klaudia Walczak Zuzanna Wesołowska Przemysław Jędruszczak |
| author_facet | Weronika Gawel Sylwia Zdun Klaudia Walczak Zuzanna Wesołowska Przemysław Jędruszczak |
| author_sort | Weronika Gawel |
| collection | DOAJ |
| description |
Introduction: Mirogabalin is a new drug from the gabapentinoid group first registered in Japan in 2019. It has found use in the treatment of peripheral neuropathic pain in diabetic neuropathy and postherpetic neuropathy.
Purpose: In this article, we review studies on the efficacy and safety of mirogabalin in the treatment of registered indications and its potentially new applications.
Materials and Methods: We reviewed the literature available in the PubMed database, using the key words: "mirogabalin", "neuropathy" "pregabalin".
Results: Mirogabalin has been registered for the treatment of neuropathic pain in diabetic neuropathy and postherpetic neuropathy. The literature shows that it is effective and safe in the above-mentioned indications. Its use has also been described: in the treatment of neuropathic pain of other etiologies with intolerance to pregabalin, as a coanalgesic in the treatment of pain in the course of cancer, and in neuropathy caused by chemotherapy. It has been shown to be effective in all of the aforementioned cases. Studies have shown no clinically significant effect of mirogabalin in the symptomatic treatment of fibromyalgia pain. It has a good safety profile and a low number of adverse effects.
Conclusions:. Mirogabalin is a drug that has the potential to improve the efficacy of treatment of neuropathic pain due to various causes. There is a need to continue conducting studies on larger groups of patients in order to make wider use of its potential in clinical practice.
|
| first_indexed | 2024-04-10T19:46:34Z |
| format | Article |
| id | doaj.art-aa99b93633a747db8b8777a35a274158 |
| institution | Directory Open Access Journal |
| issn | 2450-3118 |
| language | English |
| last_indexed | 2024-04-10T19:46:34Z |
| publishDate | 2023-01-01 |
| publisher | Nicolaus Copernicus University in Toruń |
| record_format | Article |
| series | Quality in Sport |
| spelling | doaj.art-aa99b93633a747db8b8777a35a2741582023-01-29T11:51:35ZengNicolaus Copernicus University in ToruńQuality in Sport2450-31182023-01-019110.12775/QS.2023.09.01.007Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditionsWeronika Gawel0Sylwia Zdun1Klaudia Walczak2Zuzanna Wesołowska3Przemysław Jędruszczak4Absolwent Uniwersytetu Medycznego w LublinieAbsolwent Uniwersytetu Medycznego w LublinieAbsolwent Uniwersytetu Medycznego w LublinieAbsolwent Uniwersytetu Medycznego w LublinieAbsolwent Uniwersytetu Medycznego w Lublinie Introduction: Mirogabalin is a new drug from the gabapentinoid group first registered in Japan in 2019. It has found use in the treatment of peripheral neuropathic pain in diabetic neuropathy and postherpetic neuropathy. Purpose: In this article, we review studies on the efficacy and safety of mirogabalin in the treatment of registered indications and its potentially new applications. Materials and Methods: We reviewed the literature available in the PubMed database, using the key words: "mirogabalin", "neuropathy" "pregabalin". Results: Mirogabalin has been registered for the treatment of neuropathic pain in diabetic neuropathy and postherpetic neuropathy. The literature shows that it is effective and safe in the above-mentioned indications. Its use has also been described: in the treatment of neuropathic pain of other etiologies with intolerance to pregabalin, as a coanalgesic in the treatment of pain in the course of cancer, and in neuropathy caused by chemotherapy. It has been shown to be effective in all of the aforementioned cases. Studies have shown no clinically significant effect of mirogabalin in the symptomatic treatment of fibromyalgia pain. It has a good safety profile and a low number of adverse effects. Conclusions:. Mirogabalin is a drug that has the potential to improve the efficacy of treatment of neuropathic pain due to various causes. There is a need to continue conducting studies on larger groups of patients in order to make wider use of its potential in clinical practice. https://apcz.umk.pl/QS/article/view/41950mirogabalinneuropathypregabalin |
| spellingShingle | Weronika Gawel Sylwia Zdun Klaudia Walczak Zuzanna Wesołowska Przemysław Jędruszczak Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions Quality in Sport mirogabalin neuropathy pregabalin |
| title | Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions |
| title_full | Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions |
| title_fullStr | Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions |
| title_full_unstemmed | Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions |
| title_short | Mirogabalin - the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions |
| title_sort | mirogabalin the use of a new gabapentinoid in the treatment of diabetic neuropathy and postherpetic neuropathy and other conditions |
| topic | mirogabalin neuropathy pregabalin |
| url | https://apcz.umk.pl/QS/article/view/41950 |
| work_keys_str_mv | AT weronikagawel mirogabalintheuseofanewgabapentinoidinthetreatmentofdiabeticneuropathyandpostherpeticneuropathyandotherconditions AT sylwiazdun mirogabalintheuseofanewgabapentinoidinthetreatmentofdiabeticneuropathyandpostherpeticneuropathyandotherconditions AT klaudiawalczak mirogabalintheuseofanewgabapentinoidinthetreatmentofdiabeticneuropathyandpostherpeticneuropathyandotherconditions AT zuzannawesołowska mirogabalintheuseofanewgabapentinoidinthetreatmentofdiabeticneuropathyandpostherpeticneuropathyandotherconditions AT przemysławjedruszczak mirogabalintheuseofanewgabapentinoidinthetreatmentofdiabeticneuropathyandpostherpeticneuropathyandotherconditions |